T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 941 | 910 | 1,084 | 990 | 1,096 |
| Cost of Goods | 1,627 | 2,171 | 1,894 | 1,781 | 1,026 |
| Gross Profit | -686 | -1,261 | -810 | -791 | 70 |
| Operating Expenses | 13,086 | 11,817 | 12,029 | 13,293 | 12,819 |
| Operating Income | -13,145 | -12,907 | -11,945 | -13,303 | -12,723 |
| Interest Expense | 1,637 | 1,682 | 876 | 805 | 735 |
| Other Income | 79 | 40 | 38 | 62 | 32 |
| Pre-tax Income | -14,703 | -14,549 | -12,783 | -14,046 | -13,426 |
| Net Income Continuous | -14,703 | -14,549 | -12,783 | -14,046 | -13,426 |
| Net Income | $-14,703 | $-14,549 | $-12,783 | $-14,046 | $-13,426 |
| EPS Basic Total Ops | -2,400.00 | -2,350.00 | -2,550.00 | -2,900.00 | -2,750.00 |
| EPS Basic Continuous Ops | -2,407.87 | -2,319.59 | -2,553.74 | -2,887.63 | -2,771.79 |
| EPS Diluted Total Ops | -2,400.00 | -2,350.00 | -2,550.00 | -2,900.00 | -2,750.00 |
| EPS Diluted Continuous Ops | -2,407.87 | -2,319.59 | -2,553.74 | -2,887.63 | -2,771.79 |
| EBITDA(a) | $-12,451 | $-12,253 | $-11,387 | $-12,764 | $-12,194 |